UNSPSC 51294904: Ftorpropazine

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CU0X85F735. European Medicines Agency schedules Ftorpropazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07823MIG. Ftorpropazine generally arises in the molecular formula C22H24F3N3O2S.

UNSPSC 51294904 Ftorpropazine is a Commodity code that in recent state and local procurement activity covers naloxone and drug deactivation systems for community health and emergency response. State and local health departments and county public health agencies solicit under this code to acquire pharmaceutical and medical safety products supporting overdose intervention and controlled substance management. The scope includes both naloxone units for opioid-overdose reversal and accompanying safe drug deactivation systems, typically procured through IFB notice types with fixed-fee pricing, E-Verify compliance requirements, and standard commercial insurance mandates including workers' compensation and liability coverage. Vendors must be legally authorized to work in the United States and comply with drug-free workplace certification, federal environmental regulations when FEMA funding is involved, and E-Verify employee-eligibility verification.

Seminole County, Florida posted an IFB (No. IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid response deadline was July 26, 2023, and vendors were required to include all shipping and delivery costs in their proposals. The procurement structure included an initial two-year term with an optional one-year renewal and a three-month probationary termination window. Recent activity in this code appears concentrated in Florida, with limited geographic spread evident in the available records. The code shows episodic rather than continuous activity in state and local markets, reflecting the specialized nature of naloxone and drug-safety procurement tied to community health initiatives and opioid-response programming.